Intel has made a bold move in the edge AI computing space with the launch of its Core Series 2 processors and the introduction of a dedicated Edge AI Suite for Health and Life Sciences. This announcement comes just one week after Qualcomm showcased its AI-powered Snapdragon Wear Elite chip, setting up an interesting competition between two tech giants in the burgeoning edge computing market.

According to industry analysts, Intel may have a strategic advantage over Qualcomm thanks to its extensive industrial heritage. The company claims to have shipped 250 million industrial chips over the past decade, creating a massive installed base that can potentially be upgraded to the new AI-enhanced processors. This existing ecosystem, combined with a vast library of x86 code, gives Intel a solid foundation to build upon.

The new healthcare-focused AI suite demonstrates Intel’s commitment to specialized applications, offering capabilities like AI-based ECG arrhythmia detection and real-time medical imaging processing. Early customers including Nanox.AI for medical imaging and robotics companies like Oversonic are already reporting impressive performance gains, with some claiming up to 8.3x faster processing compared to competing platforms.

👉 Read the full article on www.fiercesensors.com